Combination chemotherapy of gemcitabine and vinorelbine for pretreated non-small-cell lung cancer: a retrospective study

BACKGROUND: Advanced non-small-cell lung cancer (NSCLC) eventually progresses after first-line chemotherapy, and usually requires salvage treatment. Although neither gemcitabine nor vinorelbine is approved as a candidate drug in the second- or further-line for NSCLC, they can be alternative drugs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Minami, Seigo, Ogata, Yoshitaka, Yamamoto, Suguru, Komuta, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217520/
https://www.ncbi.nlm.nih.gov/pubmed/28210153
http://dx.doi.org/10.2147/LCTT.S89655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217520/
https://www.ncbi.nlm.nih.gov/pubmed/28210153
http://dx.doi.org/10.2147/LCTT.S89655

Ejemplares similares